Conference Proceedings

PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine plus nab-paclitaxel (GNP) chemotherapies.

Paul J Ross, Daniel Croagh, Morteza Aghmesheh, Adnan Nagrial, Nguyen Nam, Mehrdad Nikfarjam, Harpreet Singh Wasan, Thankamma V Ajithkumar, Chinenye Iwuji, Alain Hendlisz, Thomas Maher, Anna Kraszewski, Marion Harris

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2019

University of Melbourne Researchers


Funding Acknowledgements

Nab-paclitaxel was supported by Specialised Therapeutics Australia Pty Ltd.